A61P 5/34
Gestagens
A61P5/34 (Gestagens) appears on 216 US grants and 293 published applications in this corpus.
Search patents in A61P- Granted patents
- 216
- Published applications
- 293
- Assignees
- 141
- Inventors
- 584
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 11 | 0 |
| 1999 | 8 | 0 |
| 2000 | 7 | 0 |
| 2001 | 3 | 2 |
| 2002 | 7 | 11 |
| 2003 | 9 | 14 |
| 2004 | 2 | 21 |
| 2005 | 6 | 27 |
| 2006 | 6 | 22 |
| 2007 | 3 | 14 |
| 2008 | 15 | 22 |
| 2009 | 8 | 17 |
| 2010 | 16 | 26 |
| 2011 | 8 | 21 |
| 2012 | 11 | 11 |
| 2013 | 14 | 13 |
| 2014 | 15 | 13 |
| 2015 | 15 | 12 |
| 2016 | 7 | 8 |
| 2017 | 8 | 11 |
| 2018 | 6 | 6 |
| 2019 | 6 | 8 |
| 2020 | 12 | 5 |
| 2021 | 5 | 2 |
| 2022 | 3 | 1 |
| 2023 | 2 | 3 |
| 2024 | 0 | 3 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- ALA and salt formulation11 Aug 2026US 12,702,656 B2Molecular Product Management, LLC
- Implant for ovarian decline and methods of manufacturing an implant for ovarian decline5 Sep 2023US 11,744,920 B1Gameto, Inc
- High penetration compositions and their applications3 Jan 2023US 11,541,029 B2Techfields Pharma Co., Ltd.
- Vaginal sustained-release drug delivery system for luteal support, method for preparation and use thereof13 Sep 2022US 11,439,588 B2National Research Institute for Family Planning
- Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof16 Aug 2022US 11,413,294 B2Ferring B. V.
- Formulations for Prolonging Gestation and for Complications of Menstruation or Gestation31 Oct 2024US 2024/0358719 A1The Board of Trustees of the Leland Stanford Junior University
- Implant for ovarian decline and methods of manufacturing an implant for ovarian decline15 Feb 2024US 2024/0050625 A1Gameto, Inc
- Novel esters of medroxyprogesterone25 Jan 2024US 2024/0025940 A1
- High penetration compositions and their applications27 Jul 2023US 2023/0233516 A1Techfields Pharma Co., Ltd.
- Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof25 May 2023US 2023/0158044 A1Ferring B. V.
Most cited
By later US patents
- Organic compounds95US 8,664,207 B2Intra-Cellular Therapies, Inc. · 2014
- Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide94US 5,904,931 ASchering Corporation · 1999
- Gestodene-containing agent for transdermal administration73US 5,788,984 ASchering Corporation · 1998
- Progestin therapy for maintaining amenorrhea71US 6,306,914 B1Columbia Laboratories, Inc. · 2001
- Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof67US 7,431,941 B2Besins International Belgique · 2008